Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells

[Display omitted] •DNA nanostructures represent a rational and systematic way to control cell functionality.•A versatile DNA nanostructure platform modulates variety of cellular functions.•Surface functionalization of DNA nanostructures rationally controls lysosomal activity.•DNA nanostructure-based...

Full description

Saved in:

Bibliographic Details
Published in:	Chemical engineering journal (Lausanne, Switzerland : 1996) Vol. 498; p. 155633
Main Authors:	Elblová, Petra, Lunova, Mariia, Henry, Skylar J.W., Tu, Xinyi, Calé, Alicia, Dejneka, Alexandr, Havelková, Jarmila, Petrenko, Yuriy, Jirsa, Milan, Stephanopoulos, Nicholas, Lunov, Oleg
Format:	Journal Article
Language:	English
Published:	Switzerland Elsevier B.V 15-10-2024
Subjects:	Bio/nano interactions DNA nanotechnology Interferon Lysosomal rupture Lysosome interference Nanotechnology Lysosomal rupture DNA nanotechnology Lysosome interference Interferon Bio/nano interactions Nanotechnology bio/nano interactions lysosome interference
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[Display omitted] •DNA nanostructures represent a rational and systematic way to control cell functionality.•A versatile DNA nanostructure platform modulates variety of cellular functions.•Surface functionalization of DNA nanostructures rationally controls lysosomal activity.•DNA nanostructure-based platform enables control of cellular functionality. DNA nanotechnology is a rapidly growing field that provides exciting tools for biomedical applications. Targeting lysosomal functions with nanomaterials, such as DNA nanostructures (DNs), represents a rational and systematic way to control cell functionality. Here we present a versatile DNA nanostructure-based platform that can modulate a number of cellular functions depending on the concentration and surface decoration of the nanostructure. Utilizing different peptides for surface functionalization of DNs, we were able to rationally modulate lysosomal activity, which in turn translated into the control of cellular function, ranging from changes in cell morphology to modulation of immune signaling and cell death. Low concentrations of decalysine peptide-coated DNs induced lysosomal acidification, altering the metabolic activity of susceptible cells. In contrast, DNs coated with an aurein-bearing peptide promoted lysosomal alkalization, triggering STING activation. High concentrations of decalysine peptide-coated DNs caused lysosomal swelling, loss of cell–cell contacts, and morphological changes without inducing cell death. Conversely, high concentrations of aurein-coated DNs led to lysosomal rupture and mitochondrial damage, resulting in significant cytotoxicity. Our study holds promise for the rational design of a new generation of versatile DNA-based nanoplatforms that can be used in various biomedical applications, like the development of combinatorial anti-cancer platforms, efficient systems for endolysosomal escape, and nanoplatforms modulating lysosomal pH.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1385-8947
DOI:	10.1016/j.cej.2024.155633